Fundraising Fox
UCL Technology Fund
Venture capitalLondon · Pre-Seed–Seed · 13 people tracked
Find your way into UCL Technology Fund
Sign up to see every warm intro you have to UCL Technology Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the UCL Technology Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
UCL Technology Fund backs founders and research teams commercialising physical and life sciences ideas originating from University College London. Investing since 2016, the fund supports the full commercialisation journey, from proof-of-concept and development projects through to company formation. It combines capital with scale-up expertise, helping researchers turn scientific discoveries into viable companies. The fund also engages in licensing projects and proof-of-concept investments as part of translating UCL research into commercial outcomes.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website
What they invest in
from 23 of 34 portfolio companiesDeep Tech ×12Biotech ×11Healthtech ×11AI & Machine Learning ×10Medical Devices ×8Hardware ×4Enterprise Software ×3Longevity ×3
HQs:United Kingdom×9United States×2
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×32 founders×23 founders×44+ founders×1
Where their founders studiedfrom 10 founders with education data
UCL ×3Massachusetts Institute of Technology ×2University of Cambridge ×2
What their founders studiedfrom 13 founders with field-of-study data
Engineering ×7Computer Science ×4Mathematics & Statistics ×3
Where their founders worked beforefrom 13 founders with career history
UCL ×4Anthropic ×3University College London ×2University of Bristol ×2
Investments · 34 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12024 · 12023 · 12018 · 12017 · 18 dated
Meira GTx develops genetic medicine treatments for patients with devastating diseases, leveraging expertise in drug development and manufacturing.
BiotechDeep TechHealthtechMedical Devices
Alexandria Forbes(President and Chief Executive Officer and Director)Richard Giroux(Chief Operating Officer and Chief Financial Officer)Stuart Naylor(Chief Development Officer)Robert K. Zeldin(Chief Medical Officer)
Co-investorsAlbionVCOberland Capital
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.
Deep TechHardwareHealthtechMedical DevicesLondon, GB
Antony Odell(CEO & co-Founder)inMalcolm Finlay(CMO & Co-founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in
Co-investorsQueen Mary University of LondonAlbionVCNew Wave VenturesParkwalk Advisors
Gigaton builds AI control systems for cement plants that continuously learn and adapt to optimize production while reducing costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate Tech
Co-investorsClean Growth FundSemapa Next
Intrinsic Semiconductor Technologies develops resistive random-access memory (RRAM) technology for non-volatile memory applications, enabling faster data access and write speeds with lower power consumption.
AI & Machine LearningDeep TechHardwareSemiconductorsLondon, GB
Dr Adnan Mehonic(Founder)Professor Tony Kenyon(Founder)Zack Deiri(President & CEO)
Co-investorsAlbionVCOctopus Ventures
Industrial augmented reality solution guiding and monitoring shopfloor workers.
Co-investorsArmilar Venture PartnersBlueCrow CapitalCriteria Venture TechRKKVC
Tom Hooper(Founder)
Co-investorsAlbionVCBlackfinch Ventures
Anon builds agentic AI solutions that deploy AI agents from prototypes to production systems for SMBs and Fortune 500 companies.
AI & Machine LearningDeveloper ToolsEnterprise Software
Daniel Mason(Founder)Daniel Mason Kai Aichholz(Founder)Kai Aichholz(Founder)Peter Nesbitt(Founder)
Co-investorsAbstract VenturesEx/AnteImpatient VenturesPicks and Shovels (Picks & Shovels)Spice CapitalUnion Square Ventures (USV)+4 more
.jpeg){kind=logo}
A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines.
BiotechDeep TechHealthtechMedical DevicesCambridge, GB
Richard Butt(Chief Scientific Officer)inSanjay Aggarwal(Chief Medical Officer)in
Co-investorsPatient Square CapitalRock Springs CapitalAlbionVCIP Group
AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.
BiotechDeep TechHealthtechLongevityMedical Devices
Jane Rhodes(Chief Executive Officer)inMagnus Ivarsson(Chief Scientific Officer)inHannah Pearce(Chief Operating Officer)inMichelle L. Mellion(Chief Medical Officer)in
.jpg)
Co-investorsDementia Discovery FundMPM BioImpactNovartis Venture FundSV Health InvestorsAlbionVC
EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
BiotechDigital Health
Co-investorsAlbionVCMoonstone Venture CapitalXGEN VentureBritish Business BankHealth Technology Holding (HTH)
Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules.
BiotechHealthtech
Tim Wilson(Chief Executive Officer)Kevin FitzGerald(Chief Scientific Officer)inCristina Oliva(Chief Medical Officer)inNick Robbins-Cherry(Chief Financial Officer)inElizabeth Hardaker(Chief Translational Science Officer)
Co-investors3B Future Health FundAlbionVCBioGeneration VenturesEpidarex CapitalGlobal BioAccess FundNovartis Venture Fund
Freeline develops gene therapies aimed at stopping the progression of chronic diseases with single-dose genetic medicines.
BiotechHealthtechLongevity
Co-investorsAlbionVCInvivo Capital PartnersWellington Management
Gaussion develops magnetic battery control technology that improves charging speed, heat generation, and lifetime performance across different cell formats and chemistries for electric vehicles, stationary storage, and industrial applications.
Deep TechEnergyHardwareLondon, GB
Tom Heenan(Founder)in
Co-investorsAlbionVCAutotech VenturesBusiness Growth FundFuture VenturesDN CapitalePlanet Capital
Gigaton builds AI-powered control systems for energy-intensive industries to autonomously optimize operations and reduce costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate TechNew Materials
Co-investorsClean Growth FundSemapa NextAlbion Capital GroupAlbionVCPlanet A VenturesEpisode1
Hazy provides a data-sharing platform with built-in GDPR-compliant legal agreements, access controls, and audit logs to help businesses share customer data responsibly.
AI & Machine LearningCybersecurityData & Infrastructure
Harry Keen(Founder)inJames Arthur(Founder)Luke Robinson(Founder)
Co-investorsAlbionVCM12 (Microsoft's Venture Fund)Metis VenturesNeva Sgr.Notion CapitalACT Venture Partners+5 more
Humanloop was a development platform for building and managing large language model applications, providing tools for evaluating and managing AI systems.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Raza Habib(Cofounder and CEO)inJordan Burgess(CPO)inPeter Hayes(CTO)inTimo Kuschma(Head of Operations)Conor Kelly(Member of GTM Team)Marilin Berg(Growth)
Co-investorsAlbionVCIndex VenturesLocalGlobeY CombinatorEvening
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
BiotechHealthtechLongevityMedical DevicesLondon, GB
Co-investorsAlbionVC
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies for genetic and other severe diseases, including rare inherited conditions such as ADA-SCID and metachromatic leukodystrophy.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Donald Kohn(Scientific Founder)Adrian Thrasher(Scientific Founder)Frank E. Thomas(Executive Officer)inSteven M. Altschuler(Director)John Curnutte(Director)
BoardBobby Gaspar(Scientific Founder)in
Co-investorsAlbionVCF-Prime CapitalForesite Capital4BIO CapitalAgent CapitalBaillie Gifford+3 more
Oriole Networks develops PRISM, an all-optical circuit-switched networking fabric that uses photonic switching to connect GPUs at scale for AI/ML and high-performance computing data centers.
AI & Machine LearningDeep TechHardwareLondon, GB
George Zervas(Co-founder)inAlessandro Ottino(Co-founder)inJoshua Benjamin(Co-founder)inJames Regan(CEO)in
Co-investorsAlbionVCClean Growth FundPluralXTX Markets
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)inAshley Montanaro(Founder)John Morton(Founder)Toby Cubitt(Founder)
Co-investorsAlbionVCEpisode1LocalGlobePlayground GlobalLondon Co-Investment FundParkwalk Advisors+1 more
Pometry provides a temporal graph database platform with AI infrastructure tools for querying and analyzing time-aware data across business, technical, and AI agent contexts.
AI & Machine LearningData & InfrastructureEnterprise Software
Alhamza Alnaimi(Founder)in
Co-investorsAlbionVCCambridge Angels groupCrane Venture Partners
Quell Therapeutics is a clinical-stage biopharmaceutical company developing targeted Treg cell therapies with advanced manufacturing capabilities.
BiotechDeep TechHealthtechMedical Devices
Co-investorsAlbionVCJeito CapitalSV Health Investors
Spur Therapeutics develops gene therapy treatments for genetic diseases, aiming to bring genetic medicine therapies to patients worldwide.
BiotechDigital HealthHealthtechMedical Devices
BoardChris(Chair (until August 2026), Chief Executive Officer)
Co-investorsAlbionVC
Stanhope AI develops a Free Energy Minimizing (FEM) world model, an AI architecture for autonomous machines that controls behavior, enables mission planning, and supports human-machine teaming.
AI & Machine LearningDeep TechRoboticsLondon, GB
Rosalyn Moran(Founder & CEO)in
BoardKarl Friston(Scientific Adviser)
Co-investorsAlbionVCAuxxoFrontline VenturesMMC VenturesMoonfire VenturesPaladin Capital Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
0 6 Bramble Energy14 Glialign23 Odin VisionBloomsbury GTXBramble EnergyIntrinsic Semiconductor TechnologiesKIT-ARMeira GTXOdin Vision
Exits · 2
1 IPOs · 1 acquisitions · showing 121 MeiraGTxNASDAQ: MGTX
Portfolio news
latest coverage across their companiesGaussion · techfundingnews.com · Jun 29, 2026
Gigaton · finsmes.com · Jun 3, 2026
Stanhope AI · eu-startups.com · Feb 13, 2026
Epilepsy GTx · eu-startups.com · Dec 10, 2025
Frequently asked questions
- How many investments has UCL Technology Fund made?
- UCL Technology Fund has 34 tracked investments, 2 of which have exited, including 5 dated in the last 24 months.
- What stage does UCL Technology Fund invest at?
- UCL Technology Fund invests at the Pre-Seed, Seed stages.
- What is UCL Technology Fund's typical check size?
- UCL Technology Fund typically writes checks of $320K – $9M.
- What sectors does UCL Technology Fund focus on?
- UCL Technology Fund focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, IoT, Longevity, New Materials.
- Where is UCL Technology Fund located?
- UCL Technology Fund is headquartered in London, GB.
- Who does UCL Technology Fund co-invest with?
- UCL Technology Fund most often shares deals with AlbionVC, LocalGlobe, Novartis Venture Fund, among 46 tracked co-investors.
Media · Podcasts & interviews
from their channelFounder Stories University Edition with Professor Tony Kenyon, CSO & Co-founder Intrinsic.
UCL Technology Fund
Founder Stories University Edition with Ashley Montanaro, CEO & Co-founder Phasecraft
UCL Technology Fund
Founder Stories University Edition with Professor Amit Nathwani, CEO NovalGen
UCL Technology Fund
Founder Stories: Rosalyn Moran, CEO Stanhope AI
UCL Technology Fund
UCLTF Showcase 2022 - Highlights
UCL Technology Fund
Universities supporting Climate Tech - UCLTF Climate Tech Webinar
UCL Technology Fund
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Ahren Innovation Capital is a deep-tech investment firm that backs companies emerging at the intersection of breakthrough science and advanced technology, supported by science partners and strategic LP relationships.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.